1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 335 F.Supp.3d
  5. 335 F.Supp.3d 688 (2018)
 

IN RE BIOGEN '755 PATENT LITIGATION

Civil Action No.: 10-2734 (CCC)(MF) (consolidated).

335 F.Supp.3d 688 (2018)

IN RE BIOGEN '755 PATENT LITIGATION.

United States District Court, D. New Jersey.

Filed September 28, 2018.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 830 Patent
Source: PACER

Attorney(s) appearing for the Case

STEPHEN M. GREENBERG, Mediator, pro se.

BAYER HEALTHCARE PHARMACEUTICALS INC., Plaintiff, represented by ROBERT M. GOODMAN , GREENBAUM, ROWE, SMITH & DAVIS, LLP.

BIOGEN IDEC MA INC., Plaintiff Consolidated, represented by JOHN D. TORTORELLA , MARINO, TORTORELLA & BOYLE, P.C., KEVIN HARRY MARINO , MARINO TORTORELLA & BOYLE, PC & EREZ JOSEPH DAVY , MARINO, TORTORELLA & BOYLE, P.C.

BIOGEN IDEC MA INC., Defendant, represented by JOHN D. TORTORELLA , MARINO, TORTORELLA & BOYLE, P.C. & KEVIN HARRY MARINO , MARINO TORTORELLA & BOYLE, PC.

Ares Trading S.A., Defendant, pro se.

EMD SERONO, INC., PFIZER INC. & NOVARTIS PHARMACEUTICALS CORP., Defendant Consolidateds, represented by CHARLES H. CHEVALIER , GIBBONS PC, CHRISTINE A. GADDIS , GIBBONS PC & DAVID E. DELORENZI , GIBBONS, PC.

BIOGEN IDEC MA INC., Counter Claimant, represented by JOHN D. TORTORELLA , MARINO, TORTORELLA & BOYLE, P.C. & KEVIN HARRY MARINO , MARINO TORTORELLA & BOYLE, PC.

BAYER HEALTHCARE PHARMACEUTICALS INC., Counter Defendant, represented by ROBERT M. GOODMAN , GREENBAUM, ROWE, SMITH & DAVIS, LLP.

EMD SERONO, INC., Counter Claimant, represented by CHARLES H. CHEVALIER , GIBBONS PC & DAVID E. DELORENZI , GIBBONS, PC.

BIOGEN IDEC MA INC., Counter Defendant, represented by JOHN D. TORTORELLA , MARINO, TORTORELLA & BOYLE, P.C. & KEVIN HARRY MARINO , MARINO TORTORELLA & BOYLE, PC.

BAYER HEALTHCARE PHARMACEUTICALS INC., Counter Claimant, represented by ROBERT M. GOODMAN , GREENBAUM, ROWE, SMITH & DAVIS, LLP.

FRAN B. STEELE, ESQ., Trustee, pro se.

OPINION

The Court held a five-week jury trial in this patent infringement action beginning on January 18, 2018. On February 23, 2018, the jury returned a verdict finding that healthcare professionals and/or patients directly infringe claims 1 and 2 of United States Patent No. 7,588,755 (the "'755 patent") when they...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases